News

Filter

Current filters:

GenzymeOncology

1 to 9 of 14 results

UK researchers find pancreatic cancer potential for plerixafor

UK researchers find pancreatic cancer potential for plerixafor

06-01-2014

A possible new method for treating pancreatic cancer which enables the body’s immune system to attack…

GenzymeMozobilOncologyPharmaceuticalPlerixaforResearchSanofi

Sanofi pays $3 million milestone to ImmunoGen on start of SAR3419 Ph II testing; FDA accepts Aubagio filing

21-10-2011

US biotech firm ImmunoGen (Nasdaq: IMGN) says that SAR3419 has started Phase II testing, which triggers…

AubagioBiotechnologyFinancialGenzymeImmunoGenNeurologicalOncologyPharmaceuticalRegulationResearchSanofi

RXi Pharma to acquire Apthera in stock deal; Sanofi snares Genzyme

04-04-2011

Privately-held US biotech firm Apthera, which is developing a pipeline of peptide based immune-therapies,…

AptheraBiotechnologyGenzymeMergers & AcquisitionsNeuVaxOncologyPharmaceuticalRare diseasesRXi PharmaceuticalsSanofi-Aventis

Sanofi-Aventis gets EC approval for Genzyme bid; links with UCSF for early-stage research

13-01-2011

French drug major Sanofi-Aventis (Euronext: SAN) has cleared one hurdle in its quest to acquire US biotech…

DiabetesGenzymeMergers & AcquisitionsOncologyPharmaceuticalResearchSanofi-Aventis

Sanofi-Aventis debuts prostate cancer drug Jevtana in USA; Genzyme takeover still mooted

27-07-2010

Sanofi-Aventis recently announced the launch of its oncology drug, Jevtana (cabazitaxel), in the US.…

FinancialGenzymeMarkets & MarketingMergers & AcquisitionsOncologyPharmaceuticalSanofi-Aventis

1 to 9 of 14 results

Back to top